Clinical efficacy of lenvatinib for the treatment of radioiodine‐refractory thyroid carcinoma: A systematic review and meta‐analysis of clinical trials

OBJECTIVE: To evaluate the efficacy of lenvatinib in the treatment of radioiodine‐refractory thyroid carcinoma. BACKGROUND: Thyroid carcinoma is one of the top ten carcinomas worldwide. Clinically, thyroid cancers are managed with resections and adjuvant therapy with radioiodine. However, radioiodin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Zhipeng, Yang, Ming, Lai, Ching‐Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453970/
https://www.ncbi.nlm.nih.gov/pubmed/33834514
http://dx.doi.org/10.1111/cen.14479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453970/
https://www.ncbi.nlm.nih.gov/pubmed/33834514
http://dx.doi.org/10.1111/cen.14479

Ejemplares similares